128 related articles for article (PubMed ID: 1287245)
1. [Role of gut hormones in irritable bowel syndrome].
Morise K; Furusawa A; Yamamoto H; Saito H
Nihon Rinsho; 1992 Nov; 50(11):2697-702. PubMed ID: 1287245
[TBL] [Abstract][Full Text] [Related]
2. Correlation of gut hormones with irritable bowel syndrome.
Zhang H; Yan Y; Shi R; Lin Z; Wang M; Lin L
Digestion; 2008; 78(2-3):72-6. PubMed ID: 18948690
[TBL] [Abstract][Full Text] [Related]
3. Proximal and distal gut hormone secretion in irritable bowel syndrome.
Van Der Veek PP; Biemond I; Masclee AA
Scand J Gastroenterol; 2006 Feb; 41(2):170-7. PubMed ID: 16484122
[TBL] [Abstract][Full Text] [Related]
4. Abnormal levels of neuropeptide Y and peptide YY in the colon in irritable bowel syndrome.
Simrén M; Stotzer PO; Sjövall H; Abrahamsson H; Björnsson ES
Eur J Gastroenterol Hepatol; 2003 Jan; 15(1):55-62. PubMed ID: 12544695
[TBL] [Abstract][Full Text] [Related]
5. Irritable bowel syndrome: new pharmaceutical approaches to treatment.
Farthing MJ
Baillieres Best Pract Res Clin Gastroenterol; 1999 Oct; 13(3):461-71. PubMed ID: 10580922
[TBL] [Abstract][Full Text] [Related]
6. Motility disorders in the irritable bowel syndrome.
Lind CD
Gastroenterol Clin North Am; 1991 Jun; 20(2):279-95. PubMed ID: 2066153
[TBL] [Abstract][Full Text] [Related]
7. Octreotide inhibition of flushing and colonic motor dysfunction in carcinoid syndrome.
Saslow SB; O'Brien MD; Camilleri M; von der Ohe M; Homburger HA; Klee GG; Pitot HC; Rubin J
Am J Gastroenterol; 1997 Dec; 92(12):2250-6. PubMed ID: 9399764
[TBL] [Abstract][Full Text] [Related]
8. Colonic motility abnormality in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea.
Chey WY; Jin HO; Lee MH; Sun SW; Lee KY
Am J Gastroenterol; 2001 May; 96(5):1499-506. PubMed ID: 11374689
[TBL] [Abstract][Full Text] [Related]
9. An exaggerated sensory component of the gastrocolonic response in patients with irritable bowel syndrome.
Simrén M; Abrahamsson H; Björnsson ES
Gut; 2001 Jan; 48(1):20-7. PubMed ID: 11115818
[TBL] [Abstract][Full Text] [Related]
10. [Functional abnormality of the digestive tract and the gall bladder in irritable bowel syndrome].
Takahashi T
Nihon Rinsho; 1992 Nov; 50(11):2691-6. PubMed ID: 1287244
[TBL] [Abstract][Full Text] [Related]
11. Management of irritable bowel syndrome: novel approaches to the pharmacology of gut motility.
Scarpignato C; Pelosini I
Can J Gastroenterol; 1999 Mar; 13 Suppl A():50A-65A. PubMed ID: 10202210
[TBL] [Abstract][Full Text] [Related]
12. Disturbed motilin and cholecystokinin release in the irritable bowel syndrome.
Sjölund K; Ekman R; Lindgren S; Rehfeld JF
Scand J Gastroenterol; 1996 Nov; 31(11):1110-4. PubMed ID: 8938905
[TBL] [Abstract][Full Text] [Related]
13. Are gut peptides responsible for the irritable bowel syndrome (IBS)?
Sjölund K; Ekman R
Scand J Gastroenterol Suppl; 1987; 130():15-20. PubMed ID: 3477012
[TBL] [Abstract][Full Text] [Related]
14. Control of gastrointestinal motility by peptides: old peptides, new tricks--new peptides, old tricks.
Fox JA
Gastroenterol Clin North Am; 1989 Jun; 18(2):163-77. PubMed ID: 2474497
[TBL] [Abstract][Full Text] [Related]
15. [Brain-gut interactions in irritable bowel syndrome: physiological and psychological aspect].
Fukudo S; Muranaka M; Nomura T; Satake M
Nihon Rinsho; 1992 Nov; 50(11):2703-11. PubMed ID: 1337564
[TBL] [Abstract][Full Text] [Related]
16. Postprandial peptide YY release is mediated by cholecystokinin.
McFadden DW; Rudnicki M; Kuvshinoff B; Fischer JE
Surg Gynecol Obstet; 1992 Aug; 175(2):145-50. PubMed ID: 1636140
[TBL] [Abstract][Full Text] [Related]
17. Expression and role of 5-HT7 receptor in brain and intestine in rats with irritable bowel syndrome.
Zou BC; Dong L; Wang Y; Wang SH; Cao MB
Chin Med J (Engl); 2007 Dec; 120(23):2069-74. PubMed ID: 18167178
[TBL] [Abstract][Full Text] [Related]
18. Postprandial effect of gastrointestinal hormones and gastric activity in patients with irritable bowel syndrome.
Furgała A; Ciesielczyk K; Przybylska-Feluś M; Jabłoński K; Gil K; Zwolińska-Wcisło M
Sci Rep; 2023 Jun; 13(1):9420. PubMed ID: 37296188
[TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal hormones: central nervous system localization and sites of neuroendocrine actions.
Samson WK; Lumpkin MD; Vijayan E; McCann SM
Endocrinol Exp; 1982 Nov; 16(3-4):177-89. PubMed ID: 6983431
[TBL] [Abstract][Full Text] [Related]
20. Visceral hypersensitivity in irritable bowel syndrome.
Kanazawa M; Hongo M; Fukudo S
J Gastroenterol Hepatol; 2011 Apr; 26 Suppl 3():119-21. PubMed ID: 21443723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
